Fengxia Du
Impact in
-
- Cancer Genomics and Diagnostics
-
- Epigenetics and DNA Methylation
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- Cancer-related gene regulation
- Bioactive Natural Diterpenoids Research
- Renal and related cancers
Papers in
-
- Epigenetics and DNA Methylation 5
- DNA Repair Mechanisms 4
- CRISPR and Genetic Engineering 2
-
- Prostate Cancer Treatment and Research 2
- Co-authors
- Yingli Sun (9 shared papers)Caiyun Yang (7 shared papers)Minjie Zhang (6 shared papers)Huiyu Xu (1 shared paper)Jicheng Liu (1 shared paper)Jincai Hou (1 shared paper)Zhiwei Chen (1 shared paper)Wenhan Chen (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Scientific Reports (1 paper)Annals of Human Genetics (1 paper)Cell Research (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fengxia Du
27 papers receiving 315 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 58
- Molecular Biology 224
- Molecular Medicine 8
- Pharmacology 14
- Pulmonary and Respiratory Medicine 43
Countries citing papers authored by Fengxia Du
This map shows the geographic impact of Fengxia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Du more than expected).
Fields of papers citing papers by Fengxia Du
This network shows the impact of papers produced by Fengxia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Du. The network helps show where Fengxia Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxia Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 56 | |
| 2 | 2012 | 29 | |
| 3 | 2023 | 28 | |
| 4 | 2014 | 28 | |
| 5 | 2018 | 22 | |
| 6 | 2018 | 21 | |
| 7 | 2019 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2015 | 16 | |
| 10 | 2022 | 13 | |
| 11 | 2017 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2014 | 7 | |
| 14 | 2014 | 7 | |
| 15 | 2025 | 4 | |
| 16 | 2023 | 4 | |
| 17 | The radioprotective agent WR1065 protects cells from radiation damage by regulating the activity of the Tip60 acetyltransferase. | 2011 | 4 |
| 18 | 2022 | 4 | |
| 19 | 2018 | 3 | |
| 20 | 2019 | 3 |
About Fengxia Du
Fengxia Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Cancer Research, having authored 29 papers that have together received 318 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), DNA Repair Mechanisms (4 papers), CRISPR and Genetic Engineering (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (58 citations), Molecular Biology (224 citations), Molecular Medicine (8 citations), Pharmacology (14 citations) and Pulmonary and Respiratory Medicine (43 citations). Fengxia Du has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yingli Sun, Caiyun Yang, Minjie Zhang, Huiyu Xu, Jicheng Liu, Jincai Hou, Zhiwei Chen, Wenhan Chen, Shancheng Ren and Xiao Han. Their work appears in journals such as Biochemical and Biophysical Research Communications, Scientific Reports, Annals of Human Genetics, Cell Research and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.